Skip to main content
MRNA logo

MRNA · Moderna, Inc.

Track MRNA — free
$63.32 -0.33 (-0.52%) At close · Aug 14
Market Cap
$25.28B
Shares
399.24M

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2026-08-05 Bancel Stephane 499,246
2026-07-15 Hoge Stephen 53,336
2026-06-18 SAGAN PAUL 25,770
2026-06-15 Hoge Stephen 53,336
2026-06-04 Klinger Shannon Thyme 3,471
2026-05-21 Flagship Pioneering, LLC 9,263
2026-05-15 Hoge Stephen 53,336
2026-05-08 SAGAN PAUL 36,759
2026-05-01 Hussain Abbas 5,682
2026-03-02 Klinger Shannon Thyme 13,885
2026-02-23 Hoge Stephen 160,009
2025-12-11 Flagship Pioneering Inc. 23,853
2025-12-09 Hussain Abbas 504
2025-06-11 Hussain Abbas 312
2024-12-09 Klinger Shannon Thyme 529
2024-12-03 Hoge Stephen 314
2024-12-03 Klinger Shannon Thyme 112
2024-11-29 Mock James M 1,420
2024-11-29 Hoge Stephen 291
2024-11-29 Klinger Shannon Thyme 1,418
2024-11-12 Hoge Stephen 277
2024-10-07 Mock James M 715
2024-09-09 Klinger Shannon Thyme 551
2024-09-03 Klinger Shannon Thyme 114
2024-09-03 Hoge Stephen 318
2024-08-29 Hoge Stephen 300
2024-08-29 Klinger Shannon Thyme 162
2024-08-29 Mock James M 162
2024-08-28 Klinger Shannon Thyme 1,319
2024-08-28 Mock James M 1,321
2024-08-12 Hoge Stephen 254
2024-07-31 NOUBAR B AFEYAN 15,000
2024-07-24 NOUBAR B AFEYAN 15,000
2024-07-17 NOUBAR B AFEYAN 15,000
2024-07-15 Hoge Stephen 15,000
2024-07-10 NOUBAR B AFEYAN 15,000
2024-07-08 Mock James M 689
2024-06-26 NOUBAR B AFEYAN 15,000
2024-06-18 NOUBAR B AFEYAN 15,000
2024-06-17 Hoge Stephen 15,000
2024-06-12 NOUBAR B AFEYAN 15,000
2024-06-11 Flagship Ventures Fund IV-Rx, L.P. 32,763
2024-06-11 Flagship Ventures Fund IV LP 170,069
2024-06-10 Klinger Shannon Thyme 5,178
2024-06-05 NOUBAR B AFEYAN 15,000
2024-06-03 Mock James M 691
2024-06-03 Klinger Shannon Thyme 122
2024-06-03 Hoge Stephen 339
2024-05-29 Mock James M 183
2024-05-29 Hoge Stephen 341
Showing 1–50 of 157 filings
Key facts CIK 1682852 CUSIP 60770K107 13F (30d) 727 filings 689 filers Visit website Investor relations